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L,e$  "Hon&en "  HoCmqvist Abstract 
Konigsson,  K.  2001.  Induced  Parturition  and  Retained  Placenta  in  the  Cow. 
Inhibition  of  prostaglandin  Fza  synthesis  and  antibiotic  therapy  Doctor's 
dissertation. 
In order to study rapid changes in  1  5-kctodihydro-PGF2,  (PG-metabolite),  in the period 
preceding  parturition  in  cattle,  prc-term  parturition  was  induced  by  dcxamcthasonc 
injection in four heifers on days 254 to 265 in gestation. Blood samples were collected at 
least every hour until  12 hours after parturition and during the second stage of labour at 
least  6 times  per  hour.  The  average  time  from  injection  to  parturition  was  7.7 days 
(mean). Two of the  heifers  had  retained  foetal membranes  (RFM). At  the  start  of  the 
experiment the levels of PG-metabolite were low and increased  slowly to levels between 
1000 and 2000 pmoliL  at one day before parturition.  During the  last day, however, the 
levels increased rapidly and the highest levels (>10000 pmoliL) were reached at the time 
of delivery.  No pulsatile  PG-metabolite  elevations  were  seen. Immediately  after  foetal 
expulsion the PG-metabolite  levels decreased rapidly in  all animals. In  two animals with 
RFM, however, this decline ceased within a few hours postpartum  (pp). Instead the PG- 
metabolite levels started to increase and reached levels as high as during parturition. 
In another experiment the effects of the prostaglandin  synthesis inhibitor, flunixin (F) 
and oxytetracycline (T) was evaluated in cows with RFM. As a model for RFM, pre-term 
parturition was induced by injections of PGF2,.  22/24 cows had  RFM. After parturition 
the cows were divided into different groups according to the treatment. Cows were treated 
with  F,  T,  T+F  or  conservatively.  There  were  two  experiments  with  two  different 
treatment  periods  (3-6  d pp, before placental  shedding  and  11-14  d pp, after placental 
shedding). Animals treated with T on days  11  -14 had a quicker recovery from the uterine 
infection than  other cows. T  or T+F treatment  on days  3-6 did not  shorten the  uterine 
infection but altered the bacterial flora. Furthermore, T or T+F treatment at this time led 
to  improved  appetite  and  increased  energy  consumption. However,  T  or  T+F  before 
placental  shedding  delayed the  detachment  of the retained  foetal  membranes  compared 
with  other  cows.  F did not  influence  clinical  signs, recovery  from infection  or  uterine 
involution. F suppressed PG-metabolite  levels signifkantly during periods  of treatment. 
However,  treatment  on  days  3-6  suppressed  PG  synthesis  only  partially.  T  and  T+F 
before  placental  shedding  significantly  altered  the  kinetics  of  the  early PG-metabolite 
profile  compared  with  other treatments.  Late PG-metabolite  elevation  was  significantly 
correlated to the duration of the uterine infection and to the cervical involution. 
In  a  final  study,  we  wanted  to  evaluate  meloxicam  (M)  as  an  inhibitor  of  the 
inflammatory response elicited by endotoxin (ET). Furthermore, we wanted to evaluate a 
possible  effect  of  meloxicam  on  A"-rcductasc  and  15-hydroxy  prostanoatc  dehydro- 
gcnasc,  which catalysc the  flrst  steps of the metabolism  of PGF2,.  Four heifers  in mid 
luteal  phase  were  used  in  the  experiment.  ET  elicited  a rapid  PG  and  cortisol  release. 
White blood  cells, iron, zinc and calcium were affected as well. The clinical  effect was 
dramatic. Prc-treatment with M was found to abolish the PG-release totally. Furthermore, 
the cortisol release was reduced  and the effect on general appearance  and several blood 
parameters were suppressed.  M did not prevent the pyrogenic  effect of ET. M seems to 
have no major influence on the metabolism of PGF2u. 
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and Reproduction in Domestic Animals Introduction 
Parturition is commonly divided into 3 stages. The first one comprises endocrine 
and mechanical  preparation  of uterine  and cervical  tissues  for parturition.  The 
second phase involves the expulsion of the foetus and the birth of an offspring. 
The third stage involves expulsion of the placenta (Arthur et a1  1983). Thus, the 
normal postpartal period does not start until all these phases have finished. 
The actual expulsion of a calf is the result of a chain of endocrine events starting 
several weeks before parturition. Perhaps, the most important of these events is 
removal of the pregnancy preserving action of progesterone (Janszen et a1  1990). 
Termination of progesterone  synthesis before parturition  involves at least two 
different phases  in cattle (Edqvist  et a1  1978). The first occurs  during the last 
weeks of pregnancy  and is believed to be the result of a direct influence of the 
foetus on placental steroidogenic pathways. In  cattle, cortisol from foetal adrenals 
induces  a  steroidogenic  shift  in  the  placenta  (Flint  et  a1  1979).  Instead  of 
synthesising  progesterone  via  the  A4-pathway (conversion  of pregnenolone  to 
progesterone)  the  steroid  synthesis  is  switched  to  an  alternative  route,  the 
A5-pathway (conversion of pregnenolone to  17a-hydroxy-pregnenolone).  By this 
a  placental  synthesis  of  oestradiol-17P  is  initiated  and  levels  of this  steroid 
increase at the end of pregnancy at the expense of progesterone synthesis (Schuler 
et a1  1994). This can be viewed from an endocrine point of view as increasing 
levels of circulating oestradiol- 17p and declining levels of progesterone (Edqvist 
et a1  1978). The effects of the steroid synthesis shift seem to prepare the uterus for 
parturition. As a result, the levels of prostaglandin synthesising enzymes increase 
in the uterus,  cervix  and placenta  near  term (Fuchs  et a1  1999; Wimsatt  et  a1 
1993). These enzymes permit a high synthesis rate for prostaglandins F2, and E2. 
Prostaglandins  in  general  play  an  important role  in  parturition  and PGF2,  in 
particular.  PGF2,  is  important for the  final  regression  of the  corpus  luteum  of 
pregnancy.  This  is  particularly  obvious  in  mice  lacking  the prostaglandin  F- 
receptor. In such mice, PGF2, does not terminate progesterone synthesis and as a 
consequence,  parturition  does  not  occur  until  the  source  of  progesterone  is 
removed by some other means (Sugimoto et a1  1998). In  cattle, a luteolytic dose 
of PGF2,  late  in pregnancy  induces  parturition  within  48 h  (Kask  et  a1  1999; 
Kornmatitsuk  et  a1  2000),  but  if  exogenous  progesterone  is  supplied  to 
compensate  for the  loss  of endogenous  progesterone,  parturition  does not  take 
place until the exogenous progesterone is withdrawn (Janszen et a1  1990). 
PGF2,  has,  in  combination  with  oxytocin,  an  important  impact  on  uterine 
contractility. In sheep, uterine prostaglandin F and E receptor levels increase at 
term (Ma et a1  1999) and administration of PGF2, causes myometrial contractions 
when  administered  to  late  pregnant  (Janszen  et  a1  1993) and postpartal  cows 
(Thun  et  a1  1993).  Furthermore,  administration  of  exogenous  prostaglandin 
synthesis inhibitors can suppress uterine contraction antepartum (McKeown et a1 
2000).  Other prostaglandins,  like  PGE2 are important for the maturation  of the 
cervical  tissue  (Winkler et  a1  1997).  This  maturation  includes  softening  and 
dilatation  of  the  cervix  before  foetal  expulsion  and  is  characterised  by  a morphologic as well as a biochemical change of the connective tissue constituents 
(Ekman-Ordeberg & Malmstrom 1998). 
Prostaglandins are synthesised via the arachidonic acid cascade. The first step in 
this  pathway  includes  liberation  of  arachidonic  acid  from  membrane  bound 
phospholipids.  Responsible  for  this  step  is  the  calcium-dependent,  cytosolic 
phospholipase A2  (cPLA2) (Zhang et a1 1996). 
The second step includes the synthesis of the intermediate prostaglandins, PGG2 
and PGH2 by two isoenzymes, cyclooxygenase- 1 or -2 (COX-  1  or -2) (Malkowski 
et  a1  2000).  The  intermediate  prostaglandins  are  then  further  metabolised  to 
PGF2,, PGE2, PGI2 etc. 
COX-1, which  was the first  cyclooxygenase  to  be  identified, is expressed  in 
stable amounts in different tissues. It has been called the “house keeping enzyme” 
since prostaglandins synthesised by COX-  1 mainly are involved in physiological 
processes.  The  second  isoenzyme,  COX-2,  is  inducible,  short-lived  and  only 
expressed  under  certain  conditions  (Vane  &  Botting  1996).  Inflammation 
(Masferrer  et a1  1994) and parturition  (Rice  et a1  1995) are examples  of such 
conditions. 
Expression  of COX-1 and -2 in  uterine tissues  during  different reproductive 
phases has been studied in  cattle and sheep. A conclusion from these studies has 
been that levels of COX-  1  in the uterus are stable and do not vary during oestrous 
cycle and pregnancy. COX-2 levels on the other hand, are basal most of the time 
but increase during luteolysis and parturition (Johnson et a1  1995; McLaren et a1 
1996).  During  late  gestation  and parturition,  COX-2  levels  increase  in  foetal 
cotelydonary epithelium, maternal caruncular epithelium and in cervix. Increased 
levels of COX-2 have been found in the myometrium  at the time of parturition 
(Fuchs et a1 1999; Ivell et a1 2000). The increased COX-2 levels are reflected by a 
high synthesis rate of prostaglandins. 
Prostaglandin  synthesis  in  the  uterus  seems  to  be  intimately  linked  to  the 
presence  of oxytocin receptors  and the action of oxytocin (Ivell et a1 2000). In 
cattle,  oxytocin  has  been  shown  to  induce  COX-2  synthesis  and  release  of 
intracellular  calcium  (Burns  et  a1  1997).  Both  of  which  are  important  for 
activation of cPLA2 and prostaglandin synthesis. 
Prostaglandin F2,,  like other prostaglandins, has mainly paracrine actions and its 
chemical properties does not allow intracellular storage. Instead, increased plasma 
levels are a direct result of an increased synthesis rate. Once released, however, 
PGF2, has a short half-life in plasma (Samuelsson et a1  1975) and for this reason, 
measurement  in peripheral  blood  can give a  faulty picture  of the “real”  PGF2, 
synthesis. A more accurate picture of the synthesis can be achieved by measuring 
1 5-ketodihydro-PGF2,  (Kindahl  et  a1  1976). This  metabolite  is  more  stable  in 
plasma and measuring it gives a good estimation  of the uterine  PGF2, synthesis 
(Guilbault et a1 19840). 
12 Studies regarding the PGF2(, metabolite around parturition  in  cattle have  shown 
that plasma levels increase  in  late pregnancy and the highest levels are reached 
during parturition (Hunter et a1  1977; Edqvist et a1  1978; Aiumlamai et a1  1992). 
After expulsion of the foetus and the foetal membranes, PGF2, metabolite levels 
decline (Lindell et a1  1982; Guilbault et a1  19846). 
The physiological  process  of placental  detachment  is  initiated  several  weeks 
before  parturition,  but  is  not  completed  until  the  last  days  before  term.  A 
maturation process leads to a successive weakening of the borderline between the 
cotyledonary and caruncular parts of the placentome (Grunert 1986). The process 
includes  connective  tissue  remodelling  (Sharpe  et  a1  2001)  and  chemotactic 
attraction  of leucocytes  (Gunnink  1984; Heuwieser & Grunert  1987). The final 
detachment occurs along the interface between the foetal and the maternal parts of 
the placentome.  This occurs during  and after foetal expulsion. However,  if the 
maturation process is not completed before parturition, the risk for retained foetal 
membranes increases (Laven & Peters  1996). In  our model  for retained placenta 
we  used  this  matter  in  order  to  increase  the  frequency  of  retained  foetal 
membranes. 
Ideally,  the  postpartal  period  is  a  non-infectious  event.  At  parturition,  the 
contracting uterus expels the calf and the placenta. A reduction in uterine size and 
a unidirectional  flow of uterine contents as well as a gradual closure of the cervix 
prevents  introduction  of  foreign  material  and  microbial  contamination.  With 
progression of the uterine involution the risk for infection decreases. In  cows with 
retained foetal membranes, these membranes keep the cervical canal open and the 
uterine lumen distended, hence inhibiting normal uterine contraction. At the same 
time,  the  foetal  membranes  hang  out of the  vestibulum  readily  exhibited  for 
faeces and other external contaminants. The membranes move in  and out of the 
vagina  when  the  cow moves.  Hence,  contaminants  easily  pass  the  mechanical 
protective barriers and enter the uterus. An abundance of devitalised tissue and 
the impaired mechanical  and immunological  defence are important contributing 
factors for a uterine infection. 
Thus,  an  important  sequel  of  retained  foetal  membranes  in  cows  is  the 
postpartal  endometritis (Fredriksson et a1  1985). The uterine infection typically 
has  an acute and a chronic phase. In the acute phase, the dominating  bacterial 
species  are  facultative  anaerobic  bacteria  like  a-haemolytic  streptococci  and 
Escherichia coli. They are commonly isolated from the first days after parturition 
until 2 to 3 weeks pp, when they gradually disappear. In the chronic phase of the 
infection  the  dominating  species  are  instead  Arcanohacteriuin  pyogenes  and 
anaerobic bacteria like Fzisohacterium  necrophorum and Bactcroides  spp. These 
latter  species  appear  during  the  first  week  pp  and  they  usually  disappear 
spontaneously around 5 weeks pp (Fredriksson et a1 1985; Bekana et a1 1994). 
As mentioned earlier, PGF2, has important functions in bovine reproduction and 
is  physiologically  released  before,  during  and  after  parturition.  However, 
13 prostaglandins including PGF2, are also released during inflammatory processes. 
From  a  prostaglandin  point  of view,  retained  placenta  represents  a  condition 
where these two phenomena, inflammation and reproduction, meet. 
Comparisons  of cows with  and without  retained  foetal  membranes  indicate 
disparities in  postpartal  PGF2(,  metabolite profiles (Madej et a1  1986; Nakao et a1 
1997). Postpartal  PGF2, release under physiological conditions is peaking at the 
time of parturition and then gradually decline to basal levels over a period of 15 to 
20 days (Lindell et a1  1982). The PGF2, metabolite profile is characterised by an 
exponential decrease with a half-life of roughly 4 days (Kindahl et a1  1982). After 
this initial decline, no significant release occurs until after the luteolytic episodes 
at the end of the first postpartal luteal phase. 
In cows with retained foetal membranes the postpartal PGF2, metabolite profile, 
instead of declining, increases immediately after parturition (early elevation). The 
levels remain high during the first week postpartum and decrease to lower, but not 
basal, levels at  10 to  14 days after parturition  (Bolinder et a1  1988; Kask et a1 
2000).  After a  short period  of basal  PGF2(, metabolite  levels, another elevation 
starts. This elevation is of a smaller magnitude than the periparturient elevation, 
but  the  duration  is  longer.  The  second  (late)  PGF2,  metabolite  elevation  is 
correlated to the uterine infection, and is believed  to be a result  of the  uterine 
inflammation (Fredriksson et a1 1985; Del Vecchio et a1  1992; Bekana et a1 1996). 
The clinical symptoms of retained  foetal membranes  can partly be attributed to 
uterine infection and inflammation. Especially during the acute phase, there is an 
abundance of Gram negative bacteria in the uterus. E.g. E. coli, F. necruphorurn 
and Bacteroides are commonly encountered in uterine tissue during the first week 
pp and infections with  Gram negative  bacteria are known to  cause depression, 
anorexia  and  fever (Langhans  2000).  In  cows with  retained  foetal  membanes 
infection  with  these  bacterial  species  coincides  in  time  with  the  presence  of 
clinical signs like depression and fever. 
The high release of PGF2, during the acute phase of the postpartal endometritis 
might, at least partly, be related to the presence of endotoxin from Gram negative 
bacteria (Bosu et a1  1984; Slama et a1  1994). An important property of endotoxin 
is  its  ability to  activate the arachidonic  acid cascade and this  feature might  be 
crucial for the pathogenesis  of the clinical signs (Fredriksson  1984). However, 
prostaglandin synthesis as well as clinical signs of inflammation can be attenuated 
by administration of inhibitors of the arachidonic acid cascade (Jarlgv et a1  1992). 
The non-steroid anti-inflammatory drugs (NSAID) form a group of substances, 
which has in common an ability to inhibit the prostaglandin synthesis of COX-1 
and -2. Flunixin and meloxicam are two such substances registered for use in food 
producing animals. Both have been used for prevention and alleviation of clinical 
signs  like  pain  and  fever  and both  of  them  efficiently  inhibit  prostaglandin 
synthesis  (Odensvik  & Magnusson  1996;  Salamon  et  a1  2000).  Furthermore, 
flunixin has been used  for studies in postpartal cows. In those studies, intensive 
administration of flunixin already from parturition  suppresses PGF2, release, but 
14 seems to have little influence on the uterine involution  (Odensvik & Fredriksson 
1993; Thun et a1  1993). 
15 Aims 
The main objectives of this thesis were to: 
Study  the  profile  of  1 5-ketodihydro-PGF2,  before,  during  and  after 
dexamethasone-induced parturition by frequent blood sampling in cattle with and 
without retained foetal membranes. 
Evaluate  flunixin and oxytetracycline treatments of cows with induced retained 
foetal  membranes  with  regard  to  clinical,  bacteriological  and  endocrine 
parameters. 
Evaluate meloxicam as an inhibitor of endotoxin elicited disease. 
16 Methodological considerations 
Animals 
A total of 32 heifers were used, 3 1 of the Swedish red and white breed (SRB) and 
1 of the Swedish black and white breed (SLB). The ages of the animals ranged 
from 1 to 3 years. All heifers were clinically examined and found healthy before 
the  start of experiments.  Feeding  in  all  experiments  was  according  to  Swedish 
standards. 
The heifers used  in  papers  I  and IV  (n=8) were bought  from regular farms and 
brought to the Department of Obstetrics and Gynaecology, Swedish University of 
Agricultural Sciences, Uppsala, Sweden. The heifers were allowed to acclimatise 
for at least 1 week before the start of experiments. 
Heifers  used  in  papers  I1  and  I11  (n=2 x  12) belonged  to  the  Kungsangen 
research  farm,  Swedish  University  of Agricultural  Science,  Uppsala,  Sweden. 
They were born and reared on the farm. In the winter before each experiment they 
were heat-synchronised  and then artificially  inseminated. In October, they were 
brought indoors and housed in  individual pens. The experiments were performed 
in  the facilities of the research farm. After calving the cows were milked twice 
daily. 
General outline qf  experiments 
In  paper  I,  parturition  was  induced  by  injections  of  dexamethasone.  The 
experiment  lasted  from  first  injection  of dexamethasone  until  12 hours  after 
parturition.  During  the experiment  blood  samples were collected  frequently  (at 
least once per hour) and during expulsion of the foetus, at least 6 times per hour. 
Plasma was analysed for 1  5-ketodihydro-PGF2,,  progesterone and cortisol. 
In papers I1 and 111,  12 heifers were used in each of two experiments (altogether 
24  heifers),  accomplished  during  2  years.  As  a  model  for  retained  foetal 
membranes,  pre-term  parturition  was  induced  by  injections  of  PGF2,.  After 
parturition the cows were divided into 4 groups according to  treatment regime. 
The experiment  lasted  until 8 weeks postpartum. Blood  samples were collected 
for analyses  of PGF2,-metabolite,  progesterone,  white blood  cells and flunixin. 
Uterine microbiology and involution were monitored. 
In paper IV, 4 non-pregnant heifers were used for investigation of meloxicam as 
an  inhibitor of endotoxin  induced  inflammation. The heifers were  given a low 
dose  of endotoxin  with  or  without  meloxicam  pre-treatment.  In  2  additional 
experiments  PGF2,  was  given  with  or  without  meloxicam  pre-treatment.  All 
treatments were administered intravenously. 
In  the  endotoxin  experiments,  blood  samples  were  collected  for evaluation  of 
white blood  cells, plasma levels of PGF2,-metabolite,  meloxicam and cortisol as 
well  as  serum  levels  of  zinc,  iron  and  calcium.  The  heifers  were  clinically 
17 examined several times per day. In  the PGF2(,  experiments, plasma samples were 
collected for analyses of PGF2,-metabolite. 
Clinical examination 
In  papers  I1  and  111  clinical  examination  included  general  health,  nature  and 
presence  of  vaginal  discharge,  body  temperature,  food  consumption,  milk 
production  and  body  weight.  It  also  included  rectal  palpation  and  transrectal 
ultrasonography  of the  inner  genitals  including  measurement  of the cervix, the 
uterine horns and the ovaries. 
In  paper  IV,  clinical  examination  was  performed  several  times  per  day. It 
included body temperature, appetite, heart frequency and breathing frequency. 
Bacteriological sampling 
Papers I1 and 111.  Uterine bacteriology was investigated twice weekly by the use 
of a biopsy technique according to Fredriksson et a1  (1 985). The first sample was 
collected  in  the  first  week  postpartum.  The  samples  were  transported  to  the 
National  Veterinary  Institute  (SVA),  Department  of  Bacteriology.  At  the 
laboratory, the samples were used for cultivation and determination of anaerobic 
and aerobic  bacteria,  according  to  Kask  et a1  (1999).  Isolated  bacterial  strains 
were identified according to Bergey's Manual of Systematic Bacteriology (Holt et 
a1 1994). 
Blood sampling 
Papers  I  and  1V. On the  day  before  the  start of experiment  a  central  venous 
catheter was inserted into the V.  jugularis externu. The catheter was connected to 
a  silicone  tube,  which  was  led  to  the  withers.  This  allowed  frequent  blood 
sampling with minor disturbance of the animals. In  papers  I1 and 111,  blood was 
collected by venipuncture of V.  ,jugularis externu twice daily (at 8 to 9 a.m. and at 
4 to 5 p.m.). 
Immediately  after  collection,  the  tubes  were centrifuged  and then  plasma  or 
serum was  withdrawn  and transferred  to  plastic tubes.  Samples were  stored at 
-20"  C until analysis. 
Treatments 
Paper I. Dexamethasone (20 mg, Vorenvet vet. 1 mg/ml, BI-vet, Malmo, Sweden) 
was injected intramuscularly twice with a 24-hour interval on days 254-265  of 
pregnancy. 
Papers 11  and 111.  The first PGFl,-injection  (Dinolytic vet. 5 mgiml, Pharmacia- 
Upjohn, Stockholm, Sweden) was done between days 260 and 269 in pregnancy. 
During the periods of treatment, cows were treated daily with  oxytetracycline 
(Engemycin  vet.  Intervet,  Goteborg,  Sweden,  10  mg/kg,  once  daily, 
intramuscularly),  flunixin (Finadyne  vet.  Schering-Plough,  Stockholm,  Sweden, 
2.2  mg/kg  twice  daily,  by  oral  route),  a  combination  of  oxytetracycline  and 
18 flunixin (dosage as above) or conservative treatment. Flunixin was suspended in a 
bottle of water and administered via the mouth. In the first experiment the period 
of treatment was days 11 to  14 (after spontaneous placental shedding) and in the 
second, days 3 to 6 postpartum (before placental shedding). 
Paper 1V. All treatments were made intravenously on the contralateral side of the 
intravenous catheter. Endotoxin  (lipopolysaccharide  from E. coli 055:B5 1 mg, 
Sigma, Stockholm, Sweden) was diluted in physiological saline to a concentration 
of  1  pg/ml.  The dose administered was  50 ng/kg. Meloxicam  (Metacam vet. 5 
mg/ml, Boehringer-Ingelheim, Malmo, Sweden) was administered at a dose of 0.5 
mg/kg. PGF2, was diluted in physiological  saline to a final concentration of 50 
pglml. The dose administered was 0.5 pg/kg. 
Analytical methodLy 
1  5-ketodihydro-PGF2, (papers I to IV) was analysed using a radioimmunoassay 
(Granstrom and Kindahl  1982). NaHeparin  plasma was used for analysis and all 
samples were analysed in duplicates. Sensitivity of the method was 30 pmol/L. 
In  paper  1,  progesterone  in  plasma  was  analysed  by  a  solid-phase 
radioimmunoassay  technique  (Coat-A-Count  Progesterone,  Diagnostic  Products 
Corporation,  Los  Angeles,  CA, U.S.A.). The  sensitivity  of  the  assay  was  0.1 
nmol/L.  In  papers  11  and  111,  progesterone  was  analysed  using  an  enhanced 
luminescence  immunoassay  (Amerlite,  Kodak  Clinical  Diagnostic  Ltd, 
Amersham, England). Sensitivity of the assay was 0.2 nmol/L. 
Cortisol concentration  in  plasma  (paper IV) was measured by use  of an  RIA 
(Coat-A-Count Cortisol, Diagnostic Products Corporation, Los Angeles, U.S.A.). 
Detection limit for the assay was 7 nmol/L. 
Serum concentrations of calcium (paper IV) was analysed using a methylthymol 
blue method (Roche Unikit 11,  Roche Diagnostica, Basel, Switzerland). 
Serum  concentrations  of iron  (paper  IV)  was  analysed  using  a  colorimetric 
method (Roche Unimate 5,  Roche Diagnostica, Basel, Switzerland). 
Serum  concentrations  of  zinc  (paper  IV)  was  analysed  using  a  colorimetric 
method (Randox Zn-234 1, Randox Laboratories Ltd, Antrim, UK). 
An automated haematology analyser (Cell-Dyn 3500, Abbott Diagnostics) was 
used for evaluation of the total WBC count (papers 11, I11 and IV). For differential 
polymorphonuclear (PMN) and mononuclear (MN) cell count (Paper IV), smears 
were  made  immediately  after  blood  collection.  The smears  were stained  with 
May-Grunwald/Giemsa  and  the  proportions  were  obtained  by  microscopic 
counting of 200 cells. 
Flunixin  (papers  I1  and  111)  in  plasma  was  measured  by  an  HPLC  method 
described by Odensvik and Johansson (1 995). The sensitivity for the assay was 47 
ng/ml plasma. 
Plasma  levels  of meloxicam  (paper IV) were measured  by  an HPLC method 
provided by Boehringer-Ingelheim,  Ingelheim, Germany. The sensitivity for the 
method was 10 ng/ml plasma. 
19 Statistical evaluation 
Statistical analyses were calculated by  use  of Minitab  for Windows 95, release 
12.2 (Minitab Inc. PA, U.S.A.). Kruskal-Wallis test was used  for calculation of 
differences  between  groups  (papers  I I  and  I I I).  Pearson  product  moment 
correlation analyses were used for determination of the linear correlation between 
two parameters (papers I1 and 111). Results are shown as coefficient of correlation 
and p-value.  In  order  to  characterise  the  PG-metabolite  profiles,  half-lives  for 
plasma levels were used (paper 111).  Calculations were made by linear regression 
of PG-metabolite  values after logarithmic transformation.  For the levels of 15- 
ketodihydro-PGF2, (paper IV), a basal level was calculated according to Zarco et 
al. (1984). Calcium, iron, zinc and white blood  cells (paper IV) are shown with 
dot plots describing the differences between meloxicam and saline pre-treatments 
for individual heifers at each sampling occasion. 
20 Results 
PG-metabolite profiles bcfore, during and immediately after parturition in 
cows with and without retaineu'placenta (paper I) 
The pre-experimental levels of PGF2, metabolite, days 254-265  in pregnancy in 4 
heifers  ranged  from  150 to  300  pmol/L.  After  dexamethasone  injections  the 
synthesis rate of prostaglandins increased. This could be seen as increasing levels 
of the PGF2, metabolite. Two kinds of pattern of this increase were found. In the 
two heifers injected on days 264 and 265, PGF2, metabolite levels continuously 
increased  from  the  time  of  dexamethasone  injection  until  parturition.  In  the 
heifers  injected on  days 254 and 258 the  levels of PGF2, metabolite  increased 
initially  but  after  a  few days  the  levels  declined  to  levels  similar  to  the  pre- 
experimental  levels.  After  a  nadir  around  3  days  before  parturition,  a  final 
increase started and this lasted until parturition. Luteolysis occurred in all animals 
during  the  final  increase  of  PGF2,.  During  the  luteolytic  period  the  PGF2, 
metabolite levels increased rapidly but showed no signs of pulsatility. The PGF2, 
metabolite  peak  was  sharp  and  clear  in  two  heifers  with  a  quick  and  easy 
parturition (short second stage of labour) and the highest PGF2, metabolite levels 
were seen at the time of foetal expulsion. In  two heifers with a prolonged second 
stage of labour, the PGF2, metabolite peak was broadened. The PGF2, metabolite 
levels at parturition were 13000-2 1000 pmol/L. 
Immediately  after  foetal  expulsion,  the  levels  of PGF2,  metabolite  declined 
rapidly  in  all  heifers.  However,  two  of  the  four  heifers  had  retained  foetal 
membranes.  In  these heifers the immediate postpartal  PGF2, metabolite decline, 
soon (within hours) was interrupted and changed into a new period of increasing 
PGF2,  metabolite  levels.  The  magnitude  of  this  postpartal  PGF2,  metabolite 
elevation was in  the same range as the levels recorded during parturition. In  the 
two heifers in which the foetal membranes were shed at parturition, no postpartal 
increase  was  seen,  instead  PGF2,  metabolite  levels  declined  throughout  the 
experiment. 
Postpartal PG-metabolite levels in 24 cows qjter induction qj  parturition 
with PGF2, (papers 11  and IIg 
Twenty-four heifers between  260 and 269 days of gestation were  injected with 
PGF2,  twice  with  a  24-h  interval.  Parturition  occurred  within  2  (1-7)  days, 
median  (range),  of  injection  and  was  followed  by  a  high  number of retained 
placentas  (22/24). After  parturition the levels  of PGF2, metabolite  were highly 
increased in retained foetal membrane cows compared with cows where the foetal 
membranes were shed within  a few hours  after parturition. Cows with  retained 
placenta had continuously  high levels of PGF2, metabolite  after parturition  and 
maximum  levels  were  measured  1.2*0.8  days  after  parturition.  In  two  cows 
without retained foetal membranes, maximum levels were measured on the day of 
parturition. In  non-RFM cows PGF2, metabolite levels declined in an exponential 
fashion with a half-life of approximately 4 days. In non-treated MM  cows, the 
PGF2, metabolite profiles during the first 10 days pp were more or less uniform. 
21 After maximum levels around day  1  pp, PGF2(, metabolite levels declined. Also 
this decline seemed to follow an exponential decrease, but with a shorter half-life 
(0.7-1.6  days). Administration of flunixin on days 3 to 6 pp disturbed the decline. 
Cows  treated  in  this  way  showed  a  temporary  but  not  total  inhibition  of 
prostaglandin synthesis during the treatment period. In  cows treated with flunixin 
on days 11 to 14 pp, prostaglandin synthesis was temporarily inhibited during the 
treatment  period,  but  after  the  end  of  treatment,  the  levels  increased. 
Oxytetracycline treatment on days 3 to 6 resulted in  an altered PGF2(,  metabolite 
profile with a prolonged half-life (2.3-3  days). In  cows where oxytetracycline and 
flunixin  were  administered  in  combination,  flunixin  suppressed  PG-synthesis 
during the treatment period but after the end of treatment PGF2, metabolite levels 
increased again. The decline of this second elevation had a half-life of 3.5-5.4 
days. 
After 15-20  days the peripartal high levels of PG metabolite had declined in all 
cows.  The next  period  (15-40  days),  in the RFM  cows was  characterised  by 
slightly elevated levels of the PGF2(,  metabolite. This elevation was of a smaller 
magnitude  than  the  peripartal  PGF2,  metabolite  elevation.  The  end  of  this 
elevation was significantly correlated to the end of the bacterial  infection. It was 
also correlated to the final involution of cervix, but not to the involution of the 
uterine horns. 
Uterine bacteriology 
The main  bacterial  species  isolated  during  the  first  weeks  was  E. coli.  This 
species was isolated in 21/22 RFM cows. Time length of infection ranged from 9 
to 20 days and more than 75 YO  of the cows were free of E. coli by day 16 pp. E. 
coli infection did not seem to be influenced by any particular treatment. 
A.  pyogenes was isolated in 20/21 RFM cows and F. necrophorum was isolated 
in  all  RFM  cows. Time length  of infection  ranged  from  12 to  45  days. Cows 
treated  with  oxytetracycline  (solely  or  in  combination  with  flunixin)  after 
shedding of the placenta had a shorter period of infection with these bacteria than 
other RFM cows. 
a-Haemolytic streptococci were isolated  in  9/21  RFM  cows.  The last  day of 
isolation ranged from 2 to 17 days. This bacterial species seemed less frequently 
found in cows treated with oxytetracycline  before placental shedding compared 
with other cows (1/6 vs. 8/16 n.s.). 
Cows  treated  with  oxytetracycline  before  placental  shedding  had  a  higher 
proportion of Proteus spp. overgrowth compared with cows that were not treated 
with oxytetracycline before shedding, 5/6 vs. 2/16 (p<0.00 1). Similarly, isolation 
of Pusteurellu  was  more  common  in  cows treated with  oxytetracycline  before 
shedding of the foetal membranes, 4/6 vs. 3/16 (p<0.05). 
White blood cells 
The levels of white blood  cells declined significantly  during the first two days 
after parturition  in  cows with retained placenta. In  the two non-retained placenta 
cows such postpartal decline was not seen. In untreated RFM cows the postpartal 
22 drop was followed by a period of low white blood cells levels during the first 2 to 
3 weeks postpartum. The levels then gradually increased to steady levels at about 
4  weeks postpartum.  Oxytetracycline  treatment  alone  or  in  combination  with 
flunixin  days 3-6  tended to  counteract the drop in  the period  immediately post 
partum and instead of remaining on a low level, the total white blood cell count 
increased  after  oxytetracycline  treatment.  In  cows treated  with  oxytetracycline 
days  11-14  as well  as in cows solely treated  with  flunixin, the profiles  were 
similar to the profiles of the control group. 
Clinical,  findings 
In all RFM cows, the foetal membranes  were shed 6 to  15 days postpartum. In 
cows  treated  with  antibiotics  before  shedding,  the  placentas  were  shed 
approximately 2 days later (10 vs.  12 days pp) than in cows where no antibiotics 
had been given. 
The two non-RFM cows had better appetite and higher energy intake than RFM 
cows during the first 20 days. Accordingly, cows with RFM had reduced appetite 
for various times after parturition. In addition, all RFM cows had increased body 
temperature starting 2 (0-3),  median (range), and ending 11 (3-18)  days pp. 
Flunixin or oxytetracycline treatment days 11-14  had no effect on appetite or 
fever.  Furthermore,  flunixin  treatment  solely  on  days  3-6  had  no  effect  on 
appetite  or  fever.  Cows  treated  with  oxytetracycline  either  solely  or  in 
combination  with  flunixin  had  better  appetite  (seen  as a  higher  mean  energy 
intake days 6 to  10 and a shorter period of reduced appetite after parturition) than 
other RFM cows. 
Milk production and mean energy intake over the entire experimental period did 
not differ between different treatments and energy intake and milk production in 
the non-RFM cows was in the same range as in the RFM cows. 
All  RFM cows had various types and amounts of vaginal discharge during the 
postpartal period. The different types of discharge could not be correlated to any 
particular  bacterial  strain,  but  the  last  day  for  observation  of  mucopurulent 
discharge was highly correlated to the end of the bacterial infection. 
Flunixin and PGF2, metabolite (papers 11  and IIg 
Plasma  levels  of  flunixin  during  the  periods  of  treatments  were  0.17*0.01 
(meanSD) pg/ml  for cows treated days  11-14  and 0.38*0.29  pg/ml  (one cow 
had significantly higher levels than the other cows) for cows treated on days 3-6. 
Simultaneous oxytetracycline and flunixin treatments did not influence the plasma 
levels of flunixin. Flunixin treatment both during days 3 to 6 pp and days 11 to 14 
pp suppressed PGF2, synthesis. This was seen as higher mean  PGFzu metabolite 
levels during the treatment period (3-6  or 11-14  days pp) for non-flunixin treated 
than for flunixin treated cows. 
23 Clinical and endocrine @ects  of meloxicam on endotoxin elicited disease 
(Paper Iv) 
Four heifers  were given  an intravenous  bolus  injection  of  endotoxin  (E. coli 
055:B5). Ninety  minutes  before  the  injection  the heifers were pre-treated with 
either physiological saline or meloxicam. 
Endotoxin  with  saline  pre-treatment  resulted  in  an  immediate  release  of 
prostaglandins  seen  as  a  sharp  peak  of the  PGF2(,  metabolite.  In addition,  all 
heifers were severely depressed with fever, increased breathing and heart rate as 
well as total anorexia during 5-9  hours. Cortisol levels were increased during 20- 
50 hours after injection and the levels of calcium, iron and zinc were affected. The 
levels  of  polymorphonuclear  white  blood  cells  declined  immediately  after 
endotoxin injection. After a transient leucopenia of ca 10 hours, levels higher than 
the pre-experimental levels were seen. This leucocytosis lasted until the end of the 
experiment. 
Pre-treatment with meloxicam resulted in a total inhibition of endotoxin induced 
PGF2(,  release. In  addition, clinical parameters like anorexia, breathing and heart 
rates  were less  affected.  Furthermore,  cortisol  release  was reduced  and serum 
profiles of iron and zinc. The profiles of the polymorphonuclear  cells were less 
severely affected when meloxicam was injected before endotoxin and no period 
of leucocytosis  was  seen.  Meloxicam  had no  effect  on  the  endotoxin  elicited 
fever. 
24 General discussion 
Induction  of  parturition  by  dexamethasone  injection  might  mimic  the 
physiological  mechanisms by which the foetus induces parturition  in  cattle, but 
normally parturition usually occurs around day 280 in pregnancy and not as early 
as in our study.  Similarly, induction of parturition  by  injections of PGF2, days 
260 to 269 in pregnancy is a non-physiological way of inducing parturition. In a 
way, though, it is a suitable model for the studies of retained foetal membranes in 
the cow since infectious and inflammatory diseases at the end of pregnancy  are 
known to  cause abortion and, as a common sequel, retained  foetal membranes. 
PGF2, induced retained  foetal membranes as a model for postpartal disturbances 
in cattle has been evaluated by (Kask et a1  1999) and according to that study, it 
might serve as a suitable model for this disease. 
Furthermore,  intravenous  injections  of  endotoxin  is  an  extreme  model  for 
inflammatory research. No natural  infections  start as a bolus dose of endotoxin. 
More commonly, infectious agents enter the body via some other routes, inducing 
local inflammatory reactions, which in a later stage might spread to the rest of the 
body. However, for evaluations of anti-inflammatory properties of drugs, it is one 
of many models. 
The results in paper 1 indicated that PGF2, is not released in a pulsatile fashion at 
the end of pregnancy. Thus, the release pattern of PGF2, at term differs from the 
typical  “on-off’ pattern  described  in cyclic cattle (Basu & Kindahl  1987). The 
same  non-pulsatile  PGF2,  metabolite  profile  has  been  shown  earlier  in 
spontaneously  calving  cows (Aiumlamai  et  a1  1992) and  in  goats  (Ford et  a1 
1999). Instead,  of luteolytic  pulses,  the  levels  of the PGF2,1 metabolite  were 
increasing smoothly with an increasing rate close to parturition. 
The  capacity  of uterine  tissue  to  synthesise  PGF2,  increases  at  the  end  of 
pregnancy. Studies in sheep have shown that levels of cPLA2 and COX-2 increase 
in  uterine  tissue  after  glucocorticoid  induced  parturition  (Zhang  et  a1  1996). 
Furthermore,  COX-2 levels  in uterine  tissue in cows reach their highest  levels 
during  labour  (Wimsatt  et  a1  1993;  Fuchs  et  a1  1999).  Progesterone  has  an 
important role in this since this hormone regulates both the function (Grazzini et 
a1  1998) and the levels  of the oxytocin-receptors  as well  as the expression  of 
COX-2 in  uterine  tissue  (Ivell et a1  2000).  Binding of oxytocin to  its  receptor 
induces prostaglandin synthesis and is an important stimulator of COX-synthesis 
(Burns et a1 1997; Asselin et a1 200 1). 
In  paper  I  the  levels  of the PGF2, metabolite  were  the highest  at the time  of 
expulsion  in  cows with  a  normal  shedding  of the foetal  membranes,  then  the 
PGF2, metabolite levels declined throughout the experiment. Cows with retained 
foetal membranes  similarly showed high levels at expulsion and declining levels 
immediately afterwards, but this decline was soon changed into a new period of 
increasing levels. The change occurred within  a few hours after parturition  and 
the magnitude of the postpartal  PGF2, metabolite elevation was as high as during 
foetal expulsion. 
25 The postpartal  PGF2, metabolite profiles of the cows used in paper  I  have been 
described in another paper (Kask et a1  2000). In  that study and others (Bosu et a1 
1984; Madej et a1  1986; Bolinder et a1  1988) the PGF2, metabolite profiles of the 
retained  foetal  membrane  cows  were  highly  increased  for  several  days  after 
parturition. A  similar pattern  of the PGF2(, metabolite profile  was seen  in  paper 
111. 
The shedding of the foetal membranes at the time of parturition seems to have 
major consequences for the plasma levels of the maternal PGF2, metabolite in the 
peripartal  period. This might  in  part be linked to a loss of the foetal part of the 
placenta. 
During the period preceding parturition, the levels of COX-2 increase in foetal 
cotyledons  and the  COX-2 expression  reaches  its  highest  level  during  labour 
(Fuchs et a1  1999). Cotyledons have been suggested to synthesise large amounts 
of prostaglandin at term (Wimsatt et a1  1993). Thus, the shedding of the placenta 
might  remove  an  important  source  of  prostaglandins  from  the  maternal 
circulation.  In  cows without  retention  of the foetal  membranes  this  is  seen  as 
rapidly falling PGF2,  metabolite levels after the foetal expulsion. 
In cows with retained foetal membranes, on the other hand, the foetal part of the 
placenta  remains  in  contact  with  the  maternal  blood  circulation.  Thus, 
cotyledonary  tissue might  contribute to the high PGF2, metabolite  levels found 
after foetal expulsion in cows with retained foetal membranes. This possibility is 
supported  by  another  study  where  cotyledonary  tissue  in  cows with  retained 
placenta maintained its prostaglandin synthesising capacity at least 6 hours after 
foetal expulsion (Slama et a1  1994). Interestingly,  in  paper  I, the profiles of the 
PGF2,  metabolite  after  foetal  expulsion  in  heifers  A  and  D  seem  to  be  a 
continuance of the prepartal  PGF2,  metabolite profile.  A pure speculation could 
be that from an endocrine perspective, parturition is not over until the placenta is 
shed. 
An  increased  prostaglandin  synthesis  linked  to  the  parturition  might  be 
responsible for the high levels immediately post partum. However, prostaglandins 
are mediators of both physiological and pathological  events. Bearing in mind the 
uterine  infection  in  cows with retained placenta, the PGF2, metabolite elevation 
during the first days postpartum in retained foetal membrane cows might illustrate 
a transition from a physiological prostaglandin release to an inflammatory release. 
Dominating bacterial species isolated during the acute phase of the postpartal 
endometritis  are  Gram  negative  bacteria  like  E.  culi  and  F.  necruphorurn. 
Infections with these species are known to cause general depression, fever as well 
as an activation of the arachidonic acid cascade. 
From  this  perspective,  anti-inflammatory  treatment  with  the  prostaglandin 
synthesis  inhibitor flunixin  might have been a palliative  alternative to antibiotic 
therapy for cows with retained foetal membranes. Unfortunately, our studies gave 
no such indications. Reasons for this might have been the route of administration, 
or the dose. 
26 Oral administration of flunixin is an alternative to other routes of administration 
in heifers (Odensvik 1995) and orally administered flunixin was found to prevent 
endotoxin-elicited  prostaglandin  release  and  disease  in  cattle  (Odensvik  & 
Magnusson  1996). Therefore, as an alternative to  parenteral  administration, this 
route was  used  in  our  study.  Results  from the effect on  the  PGF2,  metabolite 
levels showed that the treatment via this route suppressed prostaglandin synthesis. 
Flunixin administration days 11 to  14, was more efficient from this perspective 
than treatment during days 3 to 6. 
However,  flunixin  treatment  in  the  first  days  postpartum  did not  suppress 
prostaglandin synthesis entirely. Similar results were found in another experiment 
in  cattle  (Odensvik  &  Fredriksson  1993).  In  that  study,  flunixin  had  to  be 
administered  4  times  per  day  for  complete  suppression  of the  prostaglandin 
synthesis  in  cows with  a normal  puerperium.  In  RFM  cows,  where  the  PGFzu 
metabolite levels are higher than  in  non-RFM  cows, a more intensive treatment 
might have been needed for an efficient anti-inflammatory effect. 
For  future  research  we  wanted  to  evaluate  meloxicam  as  an  inhibitor  of 
endotoxin  elicited  prostaglandin  release  in  heifers.  In  those  studies meloxicam 
completely  inhibited  prostaglandin  release  and  efficiently  reduced  the clinical 
signs of disease. In other species meloxicam  has been well tolerated, with few 
negative side effects even after long time treatment (Turck et a1  1996). A further 
advantage of meloxicam versus flunixin is the longer half-life in plasma, 20 to 30 
h  for  meloxicam  (paper  IV)  and  less  than  10 h  for  flunixin  (Odensvik  & 
Johansson  1995). This  would  allow  administration  once  daily  and  might  be a 
better alternative for treatment of retained foetal membranes. 
Oxytetracycline treatment had more influence on the clinical symptoms compared 
with  flunixin. From this point of view, the time of treatment  in relation to  the 
shedding of the foetal  membranes  seemed  important. Oxytetracycline  treatment 
on days 3 to 6 had a positive effect on the appetite. It also resulted in  a positive 
response  for the  white  blood  cells.  From an infectious  point  of  view,  though, 
oxytetracycline treatment before placental shedding did not shorten the period of 
infection, but it altered the uterine micro-flora. 
An interesting effect of this treatment regime was its influence on the placental 
shedding.  According  to  the ultrasonographic  examination  in  these  studies, the 
detachment  of the  retained  foetal membranes  is completely  different  from the 
physiological shedding of the placenta. 
Physiological  shedding of the placenta occurs along the interface between the 
foetal  and  the  maternal  parts  of  the  placentomes.  According  to  the 
ultrasonographic  examinations  of the  delayed  shedding,  the  caruncle  and  the 
remnants  of  the  cotyledons  are  shed  as  one unit.  This  has  been  reported  by 
Roberts  (1 986).  Interestingly,  on  the  caruncular  pedicle  a  hypoechoic  zone 
became  visible  around  one  week  postpartum.  During  physiologic  uterine 
involution a demarcation zone has been described on the caruncular pedicle and 
shedding of the caruncle occurs along this zone (Rasbech 1950). 
27 It  is  tempting  to  conclude  that  a  bacterial  component  is  involved  in  the 
pathological shedding of the foetal membranes, since oxytetracycline treatment on 
days 3 to 6 delayed the detachment process. Thus, shedding of the caruncle and 
the placentome might be favoured by bacterial growth and delayed by antibiotic 
therapy.  A  delayed  shedding  after  antibiotic  treatment  has  been  described 
(Roberts  1986), but  other effects of oxytetracycline and tetracycline derivatives 
than  purely  anti-microbial  are  reported.  For  instance,  oxytetracycline  has  an 
inhibiting effect on collagenases and metalloproteinases (Fecteau & Eiler  1996) 
which might contribute to the delayed shedding after oxytetracycline treatment. 
Oxytetracycline treatment on days 3 to 6 not only delayed placental shedding. It 
seemed to influence the postpartal PGF2, metabolite profiles. The half-life of the 
PGF2, metabolite in bovine plasma after infusion of PGF2, has been estimated to 
8 minutes (Kindahl et a1  1976). The PGF2, metabolite profiles  in  the postpartal 
cows  decline  with  a  “half-life”  of  several  days  (Kindahl  et  a1  1982).  The 
discrepancy in half-lives probably describes two different events. The short half- 
life is a metabolic half-life while the long half-life probably reflects a decreasing 
synthesis rate. Interestingly, this decline seems to follow a pattern, which can be 
influenced by oxytetracycline or flunixin treatment. 
Since  flunixin  inhibits  prostaglandin  synthesis  this  is  an  obvious  cause  for 
rapidly falling levels during anti-inflammatory treatment. Oxytetracycline, on the 
other  hand,  seemed to  prolong  the  half-life  of  the  PGF2,  metabolite  profile. 
Tetracycline has been shown to induce COX-2 synthesis in bovine chondrocytes 
(Attur et a1  1999). Thus, oxytetracycline might stimulate prostaglandin synthesis 
by  inducing  COX-2. However,  no effect on PGF2,  metabolite  levels  was  seen 
when oxytetracycline treatment was done days  1 1 to 14. 
Oxytetracycline  treatment  on  days  11  to  14,  after  shedding  of  the  foetal 
membranes,  led  to  quicker  recovery  from  the  uterine  infection.  This  was  in 
contrast to  oxytetracycline  treatment before  shedding of the foetal  membranes, 
where no effect on the length of the infection was seen. In earlier studies of the 
endometritis in cows with retained  foetal membranes,  increased  levels of PGF2, 
metabolite  were  found  during  the period  of uterine  infection.  The end  of this 
elevation  has  been  correlated  to  the  end  of the  uterine  infection  and hence, 
associated with  an  inflammatory response of the uterus (Fredriksson et a1  1985; 
Del Vecchio  et a1  1992). Also during  our experiments  a  significant correlation 
between the end of uterine infection and PGF2, metabolite elevations was found. 
Furthermore, the end of the PGF2, metabolite elevations was correlated to the end 
of cervical involution, leading to the suggestion that these two were linked to one 
another. In another study (Oltenacu et a1  1983), postpartal cows with abnormal 
vaginal discharge and postpartal endometritis had larger cervices and the cervical 
involution was delayed compared with postpartal  cows without discharge. Since 
inflammatory  prostaglandin  release  includes  several  other  prostaglandins  in 
addition  to  PGF2,,  we  suggested  that  also  PGEz could  be  released  during  the 
endometritis.  A  well-known  effect  of PGE2 is  its  capability  to  soften  cervical 
tissue  (Winkler et a1  1997). In  a  study by Duchens et  al.  (1993) intra-cervical 
28 application  of  PGE2  in  heifers  not only  widened  the cervix,  it  also  could  be 
measured  as  increased  plasma  levels  of  the  PGF2,  metabolite.  Our  final 
suggestion  was  that  inflammatory  mediators  might  induce  a  softening  of the 
cervix. This inhibits the final closure of the cervix, which remains patent until all 
infectious agents in the uterus are removed. 
29 General conclusions 
Frequent  blood  sampling before,  during and after parturition  in cattle indicated 
that  prepartal  15-ketodihydro-PGF2,  profiles  increases  in  a  continuous  way 
during  the  prepartal  luteolysis  and  that  PGF2a is  not  released  in  a  pulsatile 
fashion. 
The  highest  levels  of  the  PGF2,  metabolite  were  found  during  the  foetal 
expulsion.  In  cows  without  retained  foetal  membranes,  levels  decline  after 
parturition.  In  cows with  retained  foetal  membranes  however,  this  decline  is 
changed into increasing levels within a few hours after expulsion of the foetus. 
Oral administration of the prostaglandin  synthesis inhibitor flunixin at the dose 
2.2  mg/kg twice  daily, on days 3  to  6 or 11 to  14 suppressed the synthesis of 
prostaglandins  in  cows with  retained  foetal  membranes.  However,  no  clinical 
effects of the treatments were found. 
Intramuscular  administration  of oxytetracycline  (10  mg/kg) on days  11 to  14 
(after  shedding  of  the  foetal  membranes)  led  to  a  shorter  period  of uterine 
infection compared with other retained foetal membrane cows. 
Oxytetracycline  treatments  on  days  3  to  6  (before  shedding  of  the  foetal 
membranes)  had  no  effect  on  the  length  of the  uterine  infection,  but  seemed 
clinically beneficial for the cows. However, treatment at this time led to a delayed 
placental shedding and an alteration of the postpartal PGF2,1  metabolite profile. 
Meloxicam administered as a single dose 90 minutes before an intravenous bolus 
injection of endotoxin efficiently inhibited prostaglandin synthesis and suppressed 
clinical symptoms of endotoxemia. Furthermore meloxicam had no influence on 
the primary PGF2,  metabolism. Our results indicate that meloxicam  could  be a 
valuable  contribution  to  other  treatments  of  septicemic  and  inflammatory 
conditions in cattle. 
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